HB 146 - AS AMENDED BY THE HOUSE
7Apr2021... 0507h
2021 SESSION
21-0133
05/10
HOUSE BILL 146
SPONSORS: Rep. Comtois, Belk. 7; Rep. Aron, Sull. 7; Rep. Cushman, Hills. 2
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill requires health care providers to furnish upon request a list of ingredients contained in any injectable medication that is recommended or administered.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
7Apr2021... 0507h 21-0133
05/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty One
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Purity and Branding of Foods and Drugs; Medications Administered by Injection; List of Ingredients Required. Amend RSA 146 by inserting after section 6-b the following new section:
146:6-c Medications Administered by Injection; List of Ingredients Required.
I. Any prescription drug manufacturer of a medication that is administered by injection, including a vaccine, shall make a complete list of the medication's ingredients available to the public and to health care providers. Any health care provider who prescribes a vaccine or other injectable medication shall furnish, upon the request of the patient or the patient's parent or legal representative, a list of the medication's ingredients.
II. In this section:
(a) "Health care provider" means any person licensed, certified, or otherwise statutorily authorized to administer a vaccine or other injectable medication.
(b) A "list of the medication’s ingredients” means a copy of the label on the injectable medication as regulated by 21 C.F.R. section 201.100(b)(5) or as listed in the DailyMed database maintained by the United States National Library of Medicine.
III. This section shall not apply to investigational drugs or to patients involved in double blind studies, or in case of an emergency.
2 Effective Date. This act shall take effect January 1, 2022.